RUNX1 anticorps (AA 200-233)
Aperçu rapide pour RUNX1 anticorps (AA 200-233) (ABIN2616047)
Antigène
Voir toutes RUNX1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 200-233
-
Specificité
- Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.
-
Purification
- Immunogen affinity purified
-
Immunogène
- A synthetic peptide corresponding to a sequence in the middle region of human RUNX1(200-233aa ELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFN), identical to the related mouse and rat sequences.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))
-
Autre désignation
- AML1 / RUNX1
-
Sujet
-
Name/Gene ID: RUNX1
Synonyms: RUNX1, AMLCR1, Aml1 oncogene, AML1, AML1-EVI-1, CBF-alpha-2, CBFA2, Acute myeloid leukemia 1, EVI-1, PEBP2A2, PEA2-alpha B, AML1-EVI-1 fusion protein, Oncogene AML-1, PEBP2-alpha B, PEBP2aB -
ID gène
- 861
Antigène
-